Miniatura

Fitxers

LeroyD_MalJ_2019.pdf (1.69 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2019-04-10

Llicència de publicació

cc by (c) Leroy et al., 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/134963

African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1186/s12936-019-2756-4

Resum

Background: Today, the development of new and well-tolerated anti-malarial drugs is strongly justifed by the emer‑ gence of Plasmodium falciparum resistance. In 2014–2015, a phase 2b clinical study was conducted to evaluate the efcacy of a single oral dose of Artefenomel (OZ439)–piperaquine (PPQ) in Asian and African patients presenting with uncomplicated falciparum malaria. Methods: Blood samples collected before treatment ofered the opportunity to investigate the proportion of mul‑ tidrug resistant parasite genotypes, including P. falciparum kelch13 mutations and copy number variation of both P. falciparum plasmepsin 2 (Pfpm2) and P. falciparum multidrug resistance 1 (Pfmdr1) genes. Results: Validated kelch13 resistance mutations including C580Y, I543T, P553L and V568G were only detected in parasites from Vietnamese patients. In Africa, isolates with multiple copies of the Pfmdr1 gene were shown to be more frequent than previously reported (21.1%, range from 12.4% in Burkina Faso to 27.4% in Uganda). More strikingly, high proportions of isolates with multiple copies of the Pfpm2 gene, associated with piperaquine (PPQ) resistance, were frequently observed in the African sites, especially in Burkina Faso and Uganda (>30%). Conclusions: These fndings were considered to sharply contrast with the recent description of increased sensitivity to PPQ of Ugandan parasite isolates. This emphasizes the necessity to investigate in vitro susceptibility profles to PPQ of African isolates with multiple copies of the Pfpm2 gene and estimate the risk of development of PPQ resistance in Africa.

Matèries

Plasmodium falciparum, Vacuna de la malària

Matèries (anglès)

Malaria vaccine

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)

Citació

LEROY, Didier, MACINTYRE, Fiona, ADOKE, Yeka, OUOBA, Serge, BARRY, Aissata, MOMBO-NGOMA, Ghyslain, NDONG NGOMO, Jacques mari, VARO, Rosauro, DOSSOU, Yannelle, TSHEFU, Antoinette, DUONG, Tran thanh, PHUC, Bui quang, LAURIJSSENS, Bart e., KLOPPER, Roland, KHIM, Nimol, LEGRAND, Eric, MÉNARD, Didier. African isolates show a high proportion of multiple copies of
                the Plasmodium falciparum plasmepsin-2 gene, a piperaquine
                resistance marker. _Malaria Journal_. 2019. Vol. 18, núm. 126. [consulta: 30 de gener de 2026]. ISSN: 1475-2875. [Disponible a: https://hdl.handle.net/2445/134963]

Exportar metadades

JSON - METS

Compartir registre